Press Release

Global Natural Killer Cells Therapeutics Market to Be Dominated by Natural Killer Cell Directed Antibodies Segment Through 2027

Increasing prevalence of chronic diseases such as cancer is expected to drive the growth of global natural killer cells therapeutics market in the forecast period, 2023-2027.

According to TechSci Research report, “Natural killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global natural killer cells therapeutics market is anticipated to grow at an impressive rate in the forecast period, 2023-2027. This can be ascribed to the rising aging population susceptible to various chronic diseases such as heart disease, arthritis, diabetes, stroke, cancer, among others. Besides, changing lifestyle patterns, adoption of sedentary lifestyle, unhealthy eating habits, among others are further contributing towards different diseases requiring an effective and permanent treatment.  This has made the research fraternity across the globe to shift their focus in developing effective treatment for these diseases and finding the best curative treatment option. This in turn is expected to create lucrative opportunities for the growth of new treatment options such as natural killer therapeutics market over the coming next few years.

However, lack of specificity and poor in-vivo survival of the natural killer cells may hamper the market growth. Similarly, lack of specificity among natural killer cells leads to targeting the wrong cells thereby making the treatment ineffective thereby restricting the market growth. Besides, lack of awareness and affordability constraints especially in the emerging countries can further slow down the market growth of global natural killer cells therapeutics market.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Natural Killer Cells Therapeutics Market"

The global natural killer cells therapeutics market can be segmented by type, by application, by end user and by region.

Based on application, the global natural killer cells therapeutics market can be segmented into cancer, gastrointestinal diseases, immunoproliferative disorders, and others. The cancer application is expected to dominate the market during the forecast period. This can be attributed to the growing prevalence of different forms of cancers worldwide. Additionally, increase in adoption of natural killer cells therapies for treatment of various types of cancers such as acute myeloid leukemia, Hodgkin’s lymphoma, hematologic malignancies, solid tumors, cutaneous T cell lymphoma and head and neck cancer is expected to support the segmental growth and overall natural killer cells therapeutics market.

Based on end user, the global natural killer cells therapeutics market can be segmented into hospitals & clinics, academic & research institutions, and others. The academic and research institute segment is predicted to dominate the market in the forecast period. This can be ascribed to the growing research & development activities conducted by these organizations to develop an effective natural killer cells therapeutic solution for treatment of different diseases.

Major companies operating in global natural killer cells therapeutics market are:

  • Affimed N.V.
  • Century Therapeutics, Inc.
  • Celularity Inc.
  • Cytovac A/S
  • Dragonfly Therapeutics, Inc.
  • Fate Therapeutics, Inc.
  • Gamida Cell Ltd.
  • ImmunityBio, Inc.
  • Innate Pharma SA
  • Nkarta, Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • VaxCell Biotherapeutics Co., Ltd.
  • Acepodia Inc.
  • Glycostem Therapeutics B.V.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.


“The North America is expected to dominate the global natural killer cells therapeutics market on account of the growing prevalence of cancer in the region. Additionally, increasing research & development activities in the region for the development of natural killer cells therapeutics especially in the United States is expected to create lucrative opportunities for the market growth in the coming years” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others) and By Region”, has evaluated the future growth potential of global natural killer cells therapeutics market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global natural killer cells therapeutics market.


Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com

Relevant News